Home/Filings/4/0001641172-25-003093
4//SEC Filing

Lawler Joseph F. 4

Accession 0001641172-25-003093

CIK 0001815974other

Filed

Apr 6, 8:00 PM ET

Accepted

Apr 7, 9:41 PM ET

Size

7.6 KB

Accession

0001641172-25-003093

Insider Transaction Report

Form 4
Period: 2025-04-04
Lawler Joseph F.
Director10% Owner
Transactions
  • Award

    Stock Option (right to buy)

    2025-04-04+13,23613,236 total
    Exercise: $1.02Exp: 2035-04-03Common Stock (13,236 underlying)
  • Award

    Stock Option (right to buy)

    2025-04-04+25,00025,000 total
    Exercise: $1.02Exp: 2035-04-03Common Stock (25,000 underlying)
Footnotes (1)
  • [F1]The option vests on the earlier of April 4, 2026 or the date of the 2026 annual meeting of shareholders.

Documents

1 file

Issuer

Anebulo Pharmaceuticals, Inc.

CIK 0001815974

Entity typeother

Related Parties

1
  • filerCIK 0001770401

Filing Metadata

Form type
4
Filed
Apr 6, 8:00 PM ET
Accepted
Apr 7, 9:41 PM ET
Size
7.6 KB